drugset / Trial / NCT07846787

Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye Drops

NCT07846787 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multicenter, prospective, intervention study on the control of myopia in young children using high-order phase element array microstructure lenses (H.O.P.E.) in combination with low-concentration atropine eye drops (0.02%)

Timeline

Start
2026-09-30
Primary completion
2028-08-19
Completion
2028-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.02 % Other

Indications